Whitehawk Therapeutics, Inc. filed a Form 8-K at 13:04 UTC on Monday, 9 November 2026. On November 9, 2026, Whitehawk Therapeutics, Inc. (the " Company ") issued a press release announcing its financial results for the quarter ended September 30, 2026.
Form 8-K is the current report that U.S. public companies file with the SEC to disclose significant events between their regular reports. This filing reports Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
Source: U.S. Securities and Exchange Commission (EDGAR) filing